Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directionsRiccardo Gerosa, Alberto Zambelli, Rosalba Torrisi et al.|Critical Reviews in Oncology/Hematology|2024Cited by 87
Opportunities and Challenges of Synthetic Data Generation in OncologyFlavia Jacobs, Alberto Zambelli, Saverio D’Amico et al.|JCO Clinical Cancer Informatics|2023Cited by 36
Clinical Review on the Management of Breast Cancer Visceral CrisisC. Benvenuti, Alberto Zambelli, Mariangela Gaudio et al.|Biomedicines|2023Cited by 17
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systemsFlavia Jacobs, Alberto Zambelli, Saverio D’Amico et al.|Digital Health|2024Cited by 14
Potential Role of Circulating miRNAs for Breast Cancer Management in the Neoadjuvant Setting: A Road to PaveC. Benvenuti, Rita De Sanctis, Paola Tiberio et al.|Cancers|2023Cited by 13